Roger Cady - Publications, H-index & Citations

Roger Cady

Missouri State University

60H指数

301论文数

1.3W被引数

收录论文 130

发表时间

Journal of Racial and Ethnic Health Disparities

IF2.4

2025-08-06

OAAI

Amaal J. Starling; Dawn C. Buse; Roger Cady; Kevin Lenaburg; Steven Kymes

Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headache

HEADACHE

IF4

2024-06-24

OAAI

Blumenfeld, Andrew; Kudrow, David; Mcallister, Peter; Boserup, Line Pickering; Hirman, Joe; Cady, Roger

Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse

JOURNAL OF HEADACHE AND PAIN

IF7.9

2024-02-26

OAAI

Starling, Amaal J.; Cady, Roger; Buse, Dawn C.; Buzby, Meghan; Spinale, Charlie; Steinberg, Kathy; Lenaburg, Kevin; Kymes, Steven

Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records 使用人工智能在电子健康记录中识别偏头痛患者以及相关症状和状况

BMC MEDICAL INFORMATICS AND DECISION MAKING

IF3.8

2023-07-14

OAAI

Riskin, Daniel; Cady, Roger; Shroff, Anand; Hindiyeh, Nada A. A.; Smith, Timothy; Kymes, Steven

Health concerns and treatment perspectives among US adults with current versus previous high-frequency headache/migraine and acute medication overuse: The Harris Poll Migraine Report Card Survey

NEUROLOGY

IF8.5

2023-04-25

PREAI

Starling, Amaal J.; Cady, Roger; Buse, Dawn C.; Buzby, Meghan; Spinale, Charlie; Steinberg, Kathy; Kymes, Steven

NEUROLOGY

IF8.5

2023-04-25

PREAI

Buse, Dawn C.; Cady, Roger; Starling, Amaal J.; Buzby, Meghan; Spinale, Charlie; Steinberg, Kathy; Kymes, Steven

Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment

HEADACHE

IF4

2023-02-08

OAAI

Schwedt, Todd J.; Martin, Ashley; Kymes, Steven; Talon, Brian; Lee, Xin Ying; Cady, Roger; Asher, Divya; Karnik-Henry, Meghana; Mulvihill, Emily; Bates, Dawn; Beusterien, Kathleen

Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial

HEADACHE

IF4

2023-01-12

OAAI

Starling, Amaal J.; Cowan, Robert P.; Buse, Dawn C.; Diener, Hans-Christoph; Marmura, Michael J.; Hirman, Joe; Brevig, Thomas; Cady, Roger

Development and validation of a novel model for characterizing migraine outcomes within real-world data

JOURNAL OF HEADACHE AND PAIN

IF7.9

2022-09-21

OAAI

Hindiyeh, Nada A.; Riskin, Daniel; Alexander, Kimberly; Cady, Roger; Kymes, Steven

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study

JOURNAL OF HEADACHE AND PAIN

IF7.9

2022-09-06

OAAI

Cowan, Robert P.; Marmura, Michael J.; Diener, Hans-Christoph; Starling, Amaal J.; Schim, Jack; Hirman, Joe; Brevig, Thomas; Cady, Roger

Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study

JOURNAL OF HEADACHE AND PAIN

IF7.9

2022-07-28

OAAI

Cady, Roger; Lipton, Richard B.; Buse, Dawn C.; Josiassen, Mette Krog; Lindsten, Annika; Ettrup, Anders

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trials

HEADACHE

IF4

2022-05-06

OAAI

Schim, Jack D.; Anderson, Carlton; Brunner, Elizabeth; Hirman, Joe; Ogbru, Annette; Cady, Roger; McGill, Lora

Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention

HEADACHE

IF4

2022-04-25

OAAI

Lipton, Richard B.; Goadsby, Peter J.; Dodick, David W.; McGinley, James S.; Houts, Carrie R.; Wirth, R. J.; Kymes, Steve; Ettrup, Anders; Osterberg, Ole; Cady, Roger; Ashina, Messoud; Buse, Dawn C.

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine

CEPHALALGIA

IF4.6

2022-03-25

OAAI

McAllister, Peter; Kudrow, David; Cady, Roger; Hirman, Joe; Ettrup, Anders

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

CEPHALALGIA

IF4.6

2022-03-18

OAAI

Ashina, Messoud; McAllister, Peter; Cady, Roger; Hirman, Joe; Ettrup, Anders

Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2

CLINICAL THERAPEUTICS

IF3.6

2022-03-01

PREAI

Martin, Vincent; Nagy, A. Jim; Janelidze, Marina; Giorgadze, Gvantsa; Hirman, Joe; Cady, Roger; Mehta, Lahar; Buse, Dawn C.

Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine

JOURNAL OF HEADACHE AND PAIN

IF7.9

2022-02-21

OAAI

Buse, Dawn C.; Winner, Paul K.; Charleston, Larry; Hirman, Joe; Cady, Roger; Brevig, Thomas

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

JOURNAL OF HEADACHE AND PAIN

IF7.9

2022-02-07

OAAI

McAllister, Peter; Winner, Paul K.; Ailani, Jessica; Buse, Dawn C.; Lipton, Richard B.; Chakhava, George; Josiassen, Mette Krog; Lindsten, Annika; Mehta, Lahar; Ettrup, Anders; Cady, Roger

Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials

JOURNAL OF HEADACHE AND PAIN

IF7.9

2022-02-07

OAAI

Lipton, Richard B.; Charleston, Larry; Tassorelli, Cristina; Brevig, Thomas; Hirman, Joe; Cady, Roger

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

JOURNAL OF HEADACHE AND PAIN

IF7.9

2021-11-25

OAAI

Smith, Timothy R.; Spierings, Egilius L. H.; Cady, Roger; Hirman, Joe; Ettrup, Anders; Shen, Vivienne

研究方向